Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection

Infection and Immunity

Volumn 76, Issue 9, 2008, Pages 3901-3910

  De La Cruz Domínguez Punaro, María ^a   Segura, Mariela ^a   Radzioch, Danuta ^b   Rivest, Serge ^c   Gottschalk, Marcelo ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENETIC SUSCEPTIBILITY; INFECTION SENSITIVITY; INFLAMMATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS SUIS; SURVIVAL;

ANIMALS; BACTEREMIA; BLOOD; BRAIN; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; MENINGES; MICE; MICE, INBRED A; MICE, INBRED C57BL; MYOCARDIUM; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SPECIES SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SUIS; SURVIVAL ANALYSIS;

EID: 51949113737     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00350-08     Document Type: Article

References (50)

1. Al-Numani, D., M. Segura, M. Doré, and M. Gottschalk. 2003. Up-regulation of ICAM-1, CD11a/CD18 and CD11c/CD18 on human THP-1 monocytes stimulated by Streptococcus suis serotype 2. Clin. Exp. Immunol. 133: 67-77.
2. Arends, J. P., and H. C. Zanen. 1988. Meningitis caused by Streptococcus suis in humans. Rev. Infect. Dis. 10:131-137.
3. Bahloul, H., A. Mofredj, A. Mrabet, G. Gineyt, and P. Rousselier. 2008. Streptococcus suis meningitis after oral contamination? Med. Mai. Infect. 38:281-282.
4. Beaudoin, M., R. Higgins, J. Harel, and M. Gottschalk. 1992. Studies on a murine model for evaluation of virulence of Streptococcus suis capsular type 2 isolates. FEMS Microbiol. Lett. 99:111-116.
5. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12:1301-1309.
6. Chabot-Roy, G., P. J. Willson, M. Segura, S. Lacouture, and M. Gottschalk. 2006. Phagocytosis and killing of Streptococcus suis by porcine neutrophils. Microb. Pathog. 41:21-32.
7. Chiu, B.-C., V. R. Stolberg, M. Freeman, and S. W. Chensue. 2007. Mononuclear phagocyte-derived interleukin-10 suppresses the innate pulmonary granuloma cytokine response in aged mice. Am. J. Pathol. 171:829-837.
8. Cusumano, V., F. Genovese, G. Mancuso, M. Carbone, M. T. Fera, and G. Teti. 1996. Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. Infect. Immun. 64:2850-2852.
9. De Maio, A., M. L. Mooney, L. E. Matesic, C. N. Paidas, and R. H. Reeves. 1998. Genetic component in the inflammatory response induced by bacterial lipopolysaccharide. Shock 10:319-323.
10. de Waal Malefyt, R., J. Abrams, B. Bennet, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
11. Domínguez-Punaro, M. C., M. Segura, M. M. Plante, S. Lacouture, S. Rivest, and M. Gottschalk. 2007. Streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection. J. Immunol. 179:1842-1854.
12. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
13. Gingles, N. A., J. E. Alexander, A. Kadioglu, P. W. Andrew, A. Kerr, T. J. Mitchell, E. Hopes, P. Denny, S. Brown, H. B. Jones, S. Little, G. C. Booth, and W. L. McPheat. 2001. Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect. Immun. 69:426-434.
14. Goldmann, O., G. S. Chhatwal, and E. Medina. 2004. Role of host genetic factors in susceptibility to group A streptococcal infections. Indian J. Med. Res. 119(Suppl.):141-143.
15. Gottschalk, M., and M. Segura. 2000. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet. Microbiol. 76: 259-272.
16. Gottschalk, M., M. Segura, and J. Xu. 2007. Streptococcus suis infections in humans: the Chinese experience and the situation in North America. Anim. Health Res. Rev. 8:29-45.
17. Graveline, R., M. Segura, D. Radzioch, and M. Gottschalk. 2007. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int. Immunol. 19:375-389.
18. Heinzel, F. P. 1990. The role of IFN-γ in the pathology of experimental endotoxemia. J. Immunol. 145:2920-2924.
19. Heinzel, F. P., R. M. Rerko, P. Ling, J. Hakimi, and D. S. Schoenhaut. 1994. Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect. Immun. 62:4244-4249.
20. Higgins, R., and M. Gottschalk. 2005. Streptococcal diseases, p. 769-783. In B. E. Straw, S. D'Allaire, W. L. Mengelin, and D. J. Taylor (ed.), Diseases of swine. Iowa State University Press, Aimes, IA.
21. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Res. 177:1205-1208.
22. Kadioglu, A., and P. W. Andrew. 2005. Susceptibility and resistance to pneumococcal disease in mice. Brief. Funct. Genomics Proteomics 4:241-247.
23. Kataoka, Y., M. Haritani, M. Mori, M. Kishima, C. Sugimoto, M. Nakazawa, and K. Yamamoto. 1991. Experimental infections of mice and pigs with Streptococcus suis type 2. J. Vet. Med. Sci. 53:1043-1049.
24. Kerr, A. R., J. J. Irvine, J. J. Search, N. A. Gingles, A. Kadioglu, P. W. Andrew, W. L. McPheat, C. G. Booth, and T. J. Mitchell. 2002. Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect. Immun. 30:1547-1557.
25. Latifi, S. Q., M. A. O'Riordan, and A. D. Levine. 2002. Interleukin-10 controls the onset of irreversible septic shock. Infect. Immun. 70:4441-4446.
26. Lun, S., J. Perez-Casal, W. Connor, and P. Willson. 2003. Role of the suilysin in pathogenesis of Streptococcus suis capsular type 2. Microb. Pathog. 34:27-37.
27. Manley, M. O., M. A. O'Riordan, A. D. Levine, and S. Q. Latifi. 2005. Interleukin 10 extends the effectiveness of standard therapy during late sepsis with serum interleukin 6 levels predicting outcome. Shock 23:521-526.
28. Medina, E., and A. Lengeling. 2005. Genetic regulation of host responses to group A streptococcus in mice. Brief. Funct. Genomics Proteomics 4:248-257.
29. Mizrachi-Nebenzahl, Y., S. Liftshitz, R. Teitelbaum, S. Novick, A. Levi, D. Benharroch, E. Ling, and R. Dagan. 2003. Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host. Clin. Exp. Immunol. 134:23-31.
30. Mullick, A., M. Elias, S. Picard, L. Bourget, O. Jovevski, S. Gauthier, A. Tuite, P. Harakidas, C. Uihum, B. Maisse, and P. Gros. 2004. Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infect. Immun. 72:5868-5876.
31. Nguyen Thi, H. M., H. Ngo Thi, T. N. Tran Vu, L. Le Dieu, H. C. Tran Thi, X. S. Dinh, H. P. Nguyen, V. C. Ly, S. D. To, J. Campbell, T. N. Ho Dang, N. M. Tran, V. V. C. Nguyen, M. D. de Jong, T. C. Nguyen, T. H. Tran, J. Farrar, and C. Schultsz. 2008. Streptococcus suis meningitis in adults in Vietnam. Clin. Infect. Dis. 46:659-667.
32. Nilsson, U. R., and H. J. Muller-Eberhard. 1967. Deficiency of the fifth component of complement in mice with an inherited complement defect. J. Exp. Med. 125:1-16.
33. Normile, D. 2005. Infectious diseases. WHO probes deadliness of China's pig-borne disease. Science 309:1308-1309.
34. O'Malley, J., L. E. Matesic, M. C. Zink, J. D. Strandberg, M. L. Mooney, A. De Maio, and R. H. Reeves. 1998. Comparison of acute endotoxin-induced lesions in A/J and C57BL/6 mice. J. Hered. 89:525-530.
35. Ooi, Y. M., and H. R. Colten. 1979. Genetic defect in secretion of complement in C5 in mice. Nature 282:207-208.
36. Råberg, L., D. Sim, and A. F. Read. 2007. Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 318:812-814.
37. Remick, D. G., D. R. Call, S. J. Ebong. D. E. Newcomb, P. Nybom, J. A. Nemzek, and G. E. Bolgos. 2001. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality. Crit. Care Med. 29:473-481.
38. Segura, M., and M. Gottschalk. 2004. Extracellular virulence factors of streptococci associated with animal diseases. Front. Biosci. 9:1157-1188.
39. Segura, M., J. Stankova, and M. Gottschalk. 1999. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages. Infect. Immun. 67:4646-4654.
40. Segura, M., N. Vadeboacoeur, and M. Gottschalk. 2002. CD14-dependent and -independent cytokine and chemokine production by human THP-1 monocytes stimulated by Streptococcus suis capsular type 2. Clin. Exp. Immunol. 127:243-254.
41. Segura, M., G. Vanier, D. Al-Nuraani, S. Lacouture, M. Olivier, and M. Gottschalk. 2006. Proinflammatory cytokine and chemokine modulation by Streptococcus suis in a whole-blood culture system. FEMS Immunol. Med. Microbiol. 47:92-106.
42. Stewart, D., W. B. Fulton, C. Wilson, C. L. Monitto, C. N. Paidas, R. H. Reeves, and A. De Maio. 2002. Genetic contribution to the septic response in a mouse model. Shock 18:342-347.
43. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61:227-235.
44. Trentzsch, H., D. Stewart, C. N. Paidas and A. De Maio. 2003. The combination of polymicrobial sepsis and endotoxin results in an inflammatory process that could not be predicted from the independent insults. J. Surg. Res. 111:203-208.
45. Tuite, A., S. Picard, A. Mullick, and P. Gros. 2005. Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6 mice. Genes Immun. 6:672-682.
46. Vadeboncoeur, N., M. Segura, M. Doré, and M. Gottschalk. 2003. Proinflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol. Med. Microbiol. 35:49-58.
47. van Amersfoot, E. S., T. J. Berkel, and J. Kuiper. 2003. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin. Microbiol. Rev. 8:974-983.
48. van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397-5401.
49. Williams, A. E., W. F. Blakemore, and T. J. L. Alexander. 1988. A murine model of Streptococcus suis type 2 meningitis in the pig. Res. Vet. Sci. 45:394-399.
50. Yu H., H. Jing, Z. Chen, H. Zheng, X. Zhu, H. Wang, S. Wang, L. Liu, R. Zu. L. Luo, N. Xiang, H. Liu, X. Liu, Y. Shu, S. S. Lee, S. K. Chuang, Y. Wang, J. Xu, and W. Yang. 2006. Human Streptococcus suis outbreak, Sichuan, China. Emerg. Infect. Dis. 12:914-920.